What is a recommended short-acting anesthetic agent for a tubectomy (tubal ligation)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Short-Acting Anesthetic Agents for Tubectomy

For tubectomy (tubal ligation), sevoflurane or desflurane are the recommended short-acting inhalational anesthetic agents due to their rapid onset and recovery profiles, allowing for quick awakening and return of protective reflexes. 1

Anesthetic Management Algorithm for Tubectomy

Induction Options

  1. Propofol (2-3 mg/kg) - preferred induction agent due to its rapid onset, recovery profile, and reduced incidence of postoperative nausea and vomiting 1, 2
  2. Short-acting opioids for analgesia:
    • Fentanyl
    • Alfentanil
    • Remifentanil (infusion) 1

Muscle Relaxation

  • Rocuronium (0.9-1.2 mg/kg) or Succinylcholine (1-2 mg/kg) for rapid sequence induction if indicated 1
  • Complete reversal of neuromuscular blockade must be confirmed with train-of-four monitoring (TOF ≥0.9) before extubation 1

Maintenance of Anesthesia

  • Sevoflurane or Desflurane - short-acting inhalational agents that facilitate rapid awakening and return of protective reflexes 1
  • Alternative: Total intravenous anesthesia (TIVA) with propofol infusion (25-50 μg/kg/min) if patient has high risk for PONV 1, 3

Anesthetic Technique Selection

Option 1: General Anesthesia

  • Indicated for most tubectomy procedures
  • Benefits: Complete amnesia, immobility, and airway control
  • Monitor depth of anesthesia with BIS to avoid excessive depth, particularly in elderly patients (target BIS 40-60) 1

Option 2: Local Anesthesia with Sedation

  • Suitable for minimally invasive approaches in selected patients
  • Technique:
    • Local infiltration with 1.5% lidocaine with adrenaline at incision sites 2
    • Sedation with midazolam (0.07 mg/kg) and ketamine (0.3-0.5 mg/kg) 2, 4
    • Consider infiltration of uterine tubes and mesosalpinx with 0.5% bupivacaine for enhanced postoperative analgesia 5

Perioperative Considerations

Pain Management

  • Multimodal approach:
    • NSAIDs (e.g., ketorolac 30-60 mg IV) 5
    • Local anesthetic infiltration at incision sites and tubal structures 5, 6
    • Short-acting opioids as needed

PONV Prevention

  • Higher propofol infusion rates (50-75 μg/kg/min) are associated with less postoperative nausea and vomiting 3
  • Consider prophylactic antiemetics based on risk factors

Recovery Optimization

  • Monitor for respiratory depression, especially when combining sedatives and opioids
  • Early mobilization to reduce risk of venous thromboembolism

Special Considerations

Ambulatory Setting

  • Sevoflurane or desflurane preferred over longer-acting agents to facilitate same-day discharge 1
  • Avoid nitrous oxide due to increased risk of PONV and delayed bowel function 1, 7

Postpartum Tubectomy

  • Consider residual effects of pregnancy-related physiological changes
  • Higher risk of aspiration - consider rapid sequence induction
  • Local anesthetic infiltration of tubes provides superior analgesia 5

Pitfalls and Caveats

  • Avoid deep levels of anesthesia (BIS <30), particularly in elderly patients, as it may lead to hemodynamic instability and delayed recovery 1
  • Monitor respiratory parameters closely when using sedation with local anesthesia, as transient oxygen desaturation can occur with deeper sedation 3
  • Ensure complete reversal of neuromuscular blockade before extubation to prevent respiratory complications 1

The evidence strongly supports the use of short-acting agents like sevoflurane or desflurane for tubectomy procedures, with propofol as the induction agent of choice. This approach optimizes recovery time and minimizes complications, leading to improved patient outcomes in terms of morbidity and mortality.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.